Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.4757
-0.0433 (-8.34%)
Sep 21, 2026, 4:00 PM EDT - Market closed
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $1.31 million as of September 21, 2026. Its market cap has decreased by -65.39% in one year.
Market Cap
1.31M
Enterprise Value
-2.72M
1-Year Change
-65.39%
Ranking
Category
Stock Price
$0.48
ChartMarket Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $1.31M, a decrease of -99.16%. That is a compound annual growth rate of -36.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 1.31M | -49.64% |
| Dec 31, 2025 | 2.60M | 12.38% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oragenics | 2.15M |
| Curis | 2.09M |
| Virax Biolabs Group | 2.02M |
| Artelo Biosciences | 2.01M |
| Tessera Defense and Homeland Security | 1.89M |
| Valion Bio | 1.88M |
| Decoy Therapeutics | 1.82M |
| Endovia Health Sciences | 1.58M |